Product Information
FYCOMPA 4 MG TABLET is a brand product labeled by Catalyst Pharmaceuticals, Inc., priced at $39.0916 per EA under NDC 69616027430. Its NADAC has been published 133 times since Feb 7, 2024.
FDA first approved this application on Oct 22, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
4 mg/1
Manufacturer
Catalyst Pharmaceuticals, Inc.NDC
69616027430
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PERAMPANELApproval Type
New Drug (NDA)
FDA Application
NDA202834FDA Approved
10/22/2012
TE Code
AB
On Market Since
1/2/2024
Pharmacological Classes
Price Statistics
The NADAC for FYCOMPA 4 MG TABLET has been published 133 times since Feb 7, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.0916 per EA |
|---|---|
| All-time high | $39.3206 (Sep 11, 2024) |
| All-time low | $39.0916 (Aug 19, 2026) |
| 52-week high | $39.1823 |
| 52-week low | $39.0916 |
| Median price | $39.2101 |
| Average price | $39.2111 |
| Largest weekly change | +0.2% (May 22, 2024) |
| Weeks tracked | 133 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FYCOMPA 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FYCOMPA 4 MG TABLET, manufactured by Catalyst Pharmaceuticals, Inc., is $39.0916 per EA (NDC 69616027430), effective Aug 19, 2026.
How has the price of FYCOMPA 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for FYCOMPA 4 MG TABLET has held within roughly two percent of its current level. It has been tracked across 133 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for FYCOMPA 4 MG TABLET?
Since Feb 7, 2024, the NADAC for FYCOMPA 4 MG TABLET has ranged from a low of $39.0916 (Aug 19, 2026) to a high of $39.3206 (Sep 11, 2024), with a median of $39.2101 per EA.
Are there cheaper alternatives to FYCOMPA 4 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FYCOMPA 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FYCOMPA 4 MG TABLET?
FYCOMPA 4 MG TABLET (NDC 69616027430) is labeled by Catalyst Pharmaceuticals, Inc., and CMS classifies it as a brand product.